Viewing Study NCT00514293


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2025-12-25 @ 11:19 PM
Study NCT ID: NCT00514293
Status: UNKNOWN
Last Update Posted: 2014-01-10
First Post: 2007-08-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: Raghu Nandan, M.D., Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-01
Start Date Type: None
Primary Completion Date: 2011-12
Primary Completion Date Type: ESTIMATED
Completion Date: None
Completion Date Type: None
First Submit Date: 2007-08-08
First Submit QC Date: None
Study First Post Date: 2007-08-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-01-09
Last Update Post Date: 2014-01-10
Last Update Post Date Type: ESTIMATED